These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 9706170
1. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies. Genden EM, Mackinnon SE, Yu S, Flye MW. Surgery; 1998 Aug; 124(2):448-56. PubMed ID: 9706170 [Abstract] [Full Text] [Related]
2. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts. Genden EM, Mackinnon SE, Yu S, Hunter DA, Flye MW. Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773 [Abstract] [Full Text] [Related]
4. Monoclonal antibodies against ICAM-1 and LFA-1 prolong nerve allograft survival. Nakao Y, MacKinnon SE, Hertl MC, Miyasaka M, Hunter DA, Mohanakumar T. Muscle Nerve; 1995 Jan; 18(1):93-102. PubMed ID: 7800003 [Abstract] [Full Text] [Related]
5. Portal venous ultraviolet B-irradiated donor alloantigen prevents rejection in circumferential rat tracheal allografts. Genden EM, Mackinnon SE, Yu S, Hunter DA, Flye MW. Otolaryngol Head Neck Surg; 2001 May; 124(5):481-8. PubMed ID: 11337649 [Abstract] [Full Text] [Related]
6. Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. Bashuda H, Takazawa K, Tamatani T, Miyasaka M, Yagita H, Okumura K. Transplantation; 1996 Jul 15; 62(1):117-22. PubMed ID: 8693525 [Abstract] [Full Text] [Related]
7. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts. Goss JA, Nakafusa Y, Yu S, Flye MW. Transplantation; 1993 Jul 15; 56(1):166-73. PubMed ID: 8333039 [Abstract] [Full Text] [Related]
8. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T. Exp Eye Res; 1997 Jul 15; 65(1):89-98. PubMed ID: 9237869 [Abstract] [Full Text] [Related]
9. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. Miwa S, Isobe M, Suzuki J, Makuuchi M, Miyasaka M, Yamazaki S, Kawasaki S. Surgery; 1997 Jun 15; 121(6):681-9. PubMed ID: 9186469 [Abstract] [Full Text] [Related]
10. Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 antibodies. Kato Y, Yamataka A, Yagita H, Okumura K, Fujiwara T, Miyano T. Ann Surg; 1996 Jan 15; 223(1):94-100. PubMed ID: 8554424 [Abstract] [Full Text] [Related]
11. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants. Ozer K, Siemionow M. J Reconstr Microsurg; 2001 Oct 15; 17(7):511-7; discussion 518. PubMed ID: 11598825 [Abstract] [Full Text] [Related]
12. Cardiac allografts in rat recipients with simultaneous use of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies leads to accelerated graft loss. Morikawa M, Tamatani T, Miyasaka M, Uede T. Immunopharmacology; 1994 Oct 15; 28(3):171-82. PubMed ID: 7852048 [Abstract] [Full Text] [Related]
14. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K, Arima T, Yu S, Lehmann M, Flye MW. Transplantation; 2000 Jan 27; 69(2):285-93. PubMed ID: 10670640 [Abstract] [Full Text] [Related]
15. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. Goss JA, Nakafusa Y, Flye MW. Ann Surg; 1992 Oct 27; 216(4):409-14; discussion 414-6. PubMed ID: 1417190 [Abstract] [Full Text] [Related]
16. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells. Yu S, Nakafusa Y, Flye MW. Transplantation; 1997 Dec 27; 64(12):1684-8. PubMed ID: 9422402 [Abstract] [Full Text] [Related]
17. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection. Iwata T, Kamei Y, Esaki S, Takada T, Torii S, Yamashita A, Tomida S, Tamatani T, Miyasaka M, Yoshikai Y. Immunobiology; 1996 Jul 27; 195(2):160-71. PubMed ID: 8877393 [Abstract] [Full Text] [Related]
18. Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection. Ohta Y, Gotoh M, Ohzato H, Fukuzaki T, Nishihara M, Dono K, Umeshita K, Sakon M, Yagita H, Okumura K, Tanaka T, Kawashima H, Miyasaka M, Monden M. Transplantation; 1998 Apr 27; 65(8):1094-100. PubMed ID: 9583871 [Abstract] [Full Text] [Related]
19. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. Isobe M, Suzuki J, Yamazaki S, Horie S, Okubo Y, Sekiguchi M. J Heart Lung Transplant; 1997 Nov 27; 16(11):1149-56. PubMed ID: 9402515 [Abstract] [Full Text] [Related]
20. Treatment with monoclonal antibodies to ICAM-1 and LFA-1 in rat heart allograft rejection. Brandt M, Steinmann J, Steinhoff G, Haverich A. Transpl Int; 1997 Nov 27; 10(2):141-4. PubMed ID: 9090001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]